ROCKET LAB CORP (RKLB) Fundamental Analysis & Valuation

NASDAQ:RKLB • US7731211089

Current stock price

71.93 USD
+2.45 (+3.53%)
At close:
72.09 USD
+0.16 (+0.22%)
After Hours:

This RKLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RKLB Profitability Analysis

1.1 Basic Checks

  • In the past year RKLB has reported negative net income.
  • RKLB had a negative operating cash flow in the past year.
  • RKLB had negative earnings in each of the past 5 years.
  • RKLB had a negative operating cash flow in each of the past 5 years.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

  • RKLB has a Return On Assets of -8.53%. This is in the lower half of the industry: RKLB underperforms 69.23% of its industry peers.
  • RKLB's Return On Equity of -11.51% is on the low side compared to the rest of the industry. RKLB is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -8.53%
ROE -11.51%
ROIC N/A
ROA(3y)-14.66%
ROA(5y)-13.94%
ROE(3y)-31.39%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • RKLB has a better Gross Margin (34.43%) than 73.08% of its industry peers.
  • RKLB's Gross Margin has improved in the last couple of years.
  • RKLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y56.37%
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RKLB Health Analysis

2.1 Basic Checks

  • RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RKLB has more shares outstanding
  • Compared to 5 years ago, RKLB has more shares outstanding
  • RKLB has a better debt/assets ratio than last year.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • RKLB has an Altman-Z score of 39.11. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
  • RKLB has a Altman-Z score of 39.11. This is amongst the best in the industry. RKLB outperforms 98.72% of its industry peers.
  • RKLB has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of RKLB (0.10) is better than 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 39.11
ROIC/WACCN/A
WACC9.78%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • RKLB has a Current Ratio of 4.08. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
  • RKLB has a Current ratio of 4.08. This is in the better half of the industry: RKLB outperforms 71.79% of its industry peers.
  • RKLB has a Quick Ratio of 3.61. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
  • RKLB's Quick ratio of 3.61 is amongst the best of the industry. RKLB outperforms 82.05% of its industry peers.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 3.61
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. RKLB Growth Analysis

3.1 Past

  • RKLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • Looking at the last year, RKLB shows a very strong growth in Revenue. The Revenue has grown by 37.96%.
  • RKLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.43% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)37.96%
Revenue growth 3Y41.82%
Revenue growth 5Y76.43%
Sales Q2Q%35.7%

3.2 Future

  • Based on estimates for the next years, RKLB will show a very strong growth in Earnings Per Share. The EPS will grow by 39.89% on average per year.
  • Based on estimates for the next years, RKLB will show a very strong growth in Revenue. The Revenue will grow by 33.30% on average per year.
EPS Next Y42.89%
EPS Next 2Y49.01%
EPS Next 3Y39.89%
EPS Next 5YN/A
Revenue Next Year47.81%
Revenue Next 2Y43.53%
Revenue Next 3Y35.77%
Revenue Next 5Y33.3%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. RKLB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RKLB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKLB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RKLB's earnings are expected to grow with 39.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.01%
EPS Next 3Y39.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RKLB Dividend Analysis

5.1 Amount

  • RKLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RKLB Fundamentals: All Metrics, Ratios and Statistics

ROCKET LAB CORP

NASDAQ:RKLB (3/19/2026, 6:53:43 PM)

After market: 72.09 +0.16 (+0.22%)

71.93

+2.45 (+3.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners56.2%
Inst Owner Change1.23%
Ins Owners0.55%
Ins Owner Change-8.9%
Market Cap40.82B
Revenue(TTM)601.80M
Net Income(TTM)-198.21M
Analysts80
Price Target85.59 (18.99%)
Short Float %3.5%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.16%
Min EPS beat(2)4.51%
Max EPS beat(2)71.81%
EPS beat(4)3
Avg EPS beat(4)18.26%
Min EPS beat(4)-11.38%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)16.09%
EPS beat(12)9
Avg EPS beat(12)10.89%
EPS beat(16)11
Avg EPS beat(16)9.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.31%
Max Revenue beat(4)4.63%
Revenue beat(8)3
Avg Revenue beat(8)-0.39%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)30.3%
EPS NQ rev (1m)5.61%
EPS NQ rev (3m)17.62%
EPS NY rev (1m)2.71%
EPS NY rev (3m)14.59%
Revenue NQ rev (1m)3.15%
Revenue NQ rev (3m)6.05%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 67.82
P/FCF N/A
P/OCF N/A
P/B 23.71
P/tB 31.61
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.06
BVpS3.03
TBVpS2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.53%
ROE -11.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.43%
FCFM N/A
ROA(3y)-14.66%
ROA(5y)-13.94%
ROE(3y)-31.39%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y56.37%
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 355.72%
Cap/Sales 25.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.08
Quick Ratio 3.61
Altman-Z 39.11
F-Score5
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)246.33%
Cap/Depr(5y)223.49%
Cap/Sales(3y)21.24%
Cap/Sales(5y)25.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y42.89%
EPS Next 2Y49.01%
EPS Next 3Y39.89%
EPS Next 5YN/A
Revenue 1Y (TTM)37.96%
Revenue growth 3Y41.82%
Revenue growth 5Y76.43%
Sales Q2Q%35.7%
Revenue Next Year47.81%
Revenue Next 2Y43.53%
Revenue Next 3Y35.77%
Revenue Next 5Y33.3%
EBIT growth 1Y-20.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.77%
EBIT Next 3Y50.21%
EBIT Next 5Y40.47%
FCF growth 1Y-177.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-238.56%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKET LAB CORP / RKLB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROCKET LAB CORP?

ChartMill assigns a fundamental rating of 4 / 10 to RKLB.


What is the valuation status for RKLB stock?

ChartMill assigns a valuation rating of 1 / 10 to ROCKET LAB CORP (RKLB). This can be considered as Overvalued.


How profitable is ROCKET LAB CORP (RKLB) stock?

ROCKET LAB CORP (RKLB) has a profitability rating of 1 / 10.


Can you provide the financial health for RKLB stock?

The financial health rating of ROCKET LAB CORP (RKLB) is 6 / 10.